348 related articles for article (PubMed ID: 26969461)
1. A possible connection between tumor necrosis factor alpha and adropin levels in polycystic ovary syndrome.
Kume T; Calan M; Yilmaz O; Kocabas GU; Yesil P; Temur M; Bicer M; Calan OG
J Endocrinol Invest; 2016 Jul; 39(7):747-54. PubMed ID: 26969461
[TBL] [Abstract][Full Text] [Related]
2. Adropin in women with polycystic ovary syndrome.
Kuliczkowska-Płaksej J; Mierzwicka A; Jończyk M; Stachowska B; Urbanovych A; Bolanowski M
Endokrynol Pol; 2019; 70(2):151-156. PubMed ID: 30480749
[TBL] [Abstract][Full Text] [Related]
3. Association of kallistatin with carotid intima-media thickness in women with polycystic ovary syndrome.
Calan M; Guler A; Unal Kocabas G; Alarslan P; Bicer M; Imamoglu C; Yuksel A; Bozkaya G; Bilgir O
Minerva Endocrinol; 2018 Sep; 43(3):236-245. PubMed ID: 28294594
[TBL] [Abstract][Full Text] [Related]
4. The impact of serum adropin and ischemia modified albumin levels based on BMI in PCOS.
Inal ZO; Erdem S; Gederet Y; Duran C; Kucukaydin Z; Kurku H; Sakarya DK
Endokrynol Pol; 2018; 69(2):135-141. PubMed ID: 29465156
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the pro-inflammatory cytokine tumor necrosis factor-α in adolescents with polycystic ovary syndrome.
Pawelczak M; Rosenthal J; Milla S; Liu YH; Shah B
J Pediatr Adolesc Gynecol; 2014 Dec; 27(6):356-9. PubMed ID: 25256873
[TBL] [Abstract][Full Text] [Related]
6. Adropin: a key component and potential gatekeeper of metabolic disturbances in policystic ovarian syndrome.
Yildirim B; Celik O; Aydin S
Clin Exp Obstet Gynecol; 2014; 41(3):310-2. PubMed ID: 24992783
[TBL] [Abstract][Full Text] [Related]
7. The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome.
Souza Dos Santos AC; Soares NP; Costa EC; de Sá JC; Azevedo GD; Lemos TM
Gynecol Endocrinol; 2015 Mar; 31(3):225-8. PubMed ID: 25373529
[TBL] [Abstract][Full Text] [Related]
8. Adipokines, insulin-like growth factor binding protein-3 levels, and insulin sensitivity in women with polycystic ovary syndrome.
Lee H; Oh JY; Sung YA
Korean J Intern Med; 2013 Jul; 28(4):456-63. PubMed ID: 23864804
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.
Samy N; Hashim M; Sayed M; Said M
Dis Markers; 2009; 26(4):163-70. PubMed ID: 19729797
[TBL] [Abstract][Full Text] [Related]
10. Expression of the CD11c gene in subcutaneous adipose tissue is associated with cytokine level and insulin resistance in women with polycystic ovary syndrome.
Tao T; Li S; Zhao A; Zhang Y; Liu W
Eur J Endocrinol; 2012 Nov; 167(5):705-13. PubMed ID: 22945299
[TBL] [Abstract][Full Text] [Related]
11. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
12. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
Yang XF; Ren FR; Guo SP
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
[TBL] [Abstract][Full Text] [Related]
13. Preliminary study showing no association between G238A (rs361525) tumor necrosis factor-α (TNF-α) gene polymorphism and its serum level, hormonal and biochemical aspects of polycystic ovary syndrome.
Kordestani F; Mazloomi S; Mortazavi Y; Mazloomzadeh S; Fathi M; Rahmanpour H; Nazarian A
BMC Med Genet; 2018 Aug; 19(1):149. PubMed ID: 30134857
[TBL] [Abstract][Full Text] [Related]
14. Serum asymmetric dimethylarginine, apelin, and tumor necrosis factor-α levels in non-obese women with polycystic ovary syndrome.
Choi YS; Yang HI; Cho S; Jung JA; Jeon YE; Kim HY; Seo SK; Lee BS
Steroids; 2012 Nov; 77(13):1352-8. PubMed ID: 22944040
[TBL] [Abstract][Full Text] [Related]
15. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea.
Vgontzas AN; Trakada G; Bixler EO; Lin HM; Pejovic S; Zoumakis E; Chrousos GP; Legro RS
Metabolism; 2006 Aug; 55(8):1076-82. PubMed ID: 16839844
[TBL] [Abstract][Full Text] [Related]
16. Potential effects of adropin on systemic metabolic and hormonal abnormalities in polycystic ovary syndrome.
Ye Z; Zhang C; Zhao Y
Reprod Biomed Online; 2021 May; 42(5):1007-1014. PubMed ID: 33612434
[TBL] [Abstract][Full Text] [Related]
17. Circulating insulin-like peptide 5 levels and its association with metabolic and hormonal parameters in women with polycystic ovary syndrome.
Bicer M; Alan M; Alarslan P; Guler A; Kocabas GU; Imamoglu C; Aksit M; Bozkaya G; Isil AM; Baloglu A; Aslanipoiur B; Calan M
J Endocrinol Invest; 2019 Mar; 42(3):303-312. PubMed ID: 29956214
[TBL] [Abstract][Full Text] [Related]
18. Obesity, but not polycystic ovary syndrome, affects circulating markers of low-grade inflammation in young women without major cardiovascular risk factors.
Barcellos CR; Rocha MP; Hayashida SA; Dantas WS; Dos Reis Vieira Yance V; Marcondes JA
Hormones (Athens); 2015; 14(2):251-7. PubMed ID: 26158655
[TBL] [Abstract][Full Text] [Related]
19. [Correlations between adipocytokines and insulin resistance in women with polycystic ovary syndrome].
Li X; Li X; Huang HY; Ma D; Zhu MW; Lin JF
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2607-10. PubMed ID: 20137676
[TBL] [Abstract][Full Text] [Related]
20. Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome.
Lauria PB; Del Puerto HL; Reis AM; Candido AL; Reis FM
J Clin Endocrinol Metab; 2013 Dec; 98(12):4882-9. PubMed ID: 24057296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]